Form 4 for BMY Bristol Myers Squibb
Accepted 2026-09-10 16:37:19 ET · period of report 2026-09-09 · accession 0002080176-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 16:37 | 2026-09-09 | BMY | Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | S - Sale | $64.57 | -6,249 | 18.7K | -25% | -$403.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.10 par value | 2026-09-09 | S | D | 6,249 | $64.57 | 18,748 | D | — | — |